In Being Patient’s LiveTalk series, retired family physician Dewayne Nash spoke about life after an early diagnosis of Alzheimer’s, his involvement as a subject…
Scientists are exploring an affordable way to fight early memory loss by studying the effects of nicotine patches for patients with mild cognitive impairment,…
Another development in Alzheimer’s diagnosis and treatment has earned the FDA’s “breakthrough” designation — but this one is not a drug. It’s a virtual…
Laurie Archbald-Pannone, associate professor of medicine and geriatrics at the University of Virginia, explores the difference between normal memory loss and more severe cognitive…
Amylyx Pharmaceuticals’ neurodegeneration drug, AMX0035, has been studied in volunteers with mild cognitive impairment (MCI) or Alzheimer’s in a Phase 2 clinical trial. Topline…
How can we differentiate between “normal” aging and mild cognitive impairment, the condition associated with early stages of neurodegenerative diseases like Alzheimer’s? Aging can…
New research has uncovered proteins coded by genes of the female sex chromosome that may explain why women are more resilient to the disease….